Efficacy of Habb-e-Asab in diabetic peripheral neuropathy: a randomized placebo control study.
Fathima Nafha NizamdeenMohd Aleemuddin QuamriMd Anzar AlamPublished in: Journal of basic and clinical physiology and pharmacology (2022)
for 45 days improved and reduced the severity of DPN in a patient with diabetes (CTRI/2018/02/011725).